FIB4 EASL 路径在普通人群中分层脂肪性肝病风险准确性差且可持续性不佳
该研究基于 NHANES17-18(3372 人)、UK Biobank(300329 人)和 Biobank Japan(57644 人)评估 EASL 第一步 FIB4 路径在普通人群 SLD 风险分层中的表现。FIB4 对 LSM≥8 kPa 的敏感性低(27.7%),但对 3 年肝脏相关事件敏感性约 80%-90%;22%-57% 受试者被判定为需 VCTE 检查,其中多数可避免。作者认为该路径准确性差、可行性低,需改进第一步筛查策略。
要点
- FIB4 对 LSM≥8 kPa 敏感性仅 27.7%,对 3 年肝脏相关事件敏感性约 80%-90%。
- FIB4≥1.3 预测 LSM≥8 kPa 的阳性预测值在不同 SLD 类别中仅 9.5%-13%,多数 VCTE 可避免。
- 敏感性随酒精摄入量增加(ALD>MetALD>MASLD)和年龄增长而升高;≥65 岁用年龄调整切点(≥2)大幅降低敏感性。
核心结论
- EASL 第一步 FIB4 路径在普通人群 SLD 风险个体中准确性差、可行性低,亟需改进第一步筛查策略以减少不必要的 VCTE 并优化其产出。
研究设计与样本
- 以 LSM≥8 kPa 及 3 年和 10 年内肝脏相关事件为结局,按近期国际建议定义 MASLD、MetALD 和 ALD。
主要发现
- FIB4 对 LSM≥8 kPa 的敏感性为 27.7%,对 3 年肝脏相关事件敏感性约 80%-90%。
- 三个队列中 22%-57% 的受试者被识别为 VCTE 候选者,FIB4≥1.3 预测 LSM≥8 kPa 的阳性预测值在不同 SLD 类别中为 9.5%-13%。
- FIB4 对 LSM≥8 kPa 和肝脏相关事件的敏感性随酒精摄入量增加(ALD>MetALD>MASLD)和年龄增长而升高。
- ≥65 岁个体使用推荐的年龄调整 FIB4 切点(≥2)大幅降低了对 LSM≥8 kPa 和肝脏相关事件的敏感性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The European Association for the Study of the Liver introduced a clinical pathway (EASL CP) for screening significant/advanced fibrosis in people at risk of steatotic liver disease (SLD). We assessed the performance of the first-step FIB4 EASL CP in the general population across different SLD risk groups (MASLD, Met-ALD and ALD) and various age classes. METHODS: We analysed a total of 3372 individuals at risk of SLD from the 2017-2018 National Health and Nutrition Examination Survey (NHANES17-18), projected to 152.3 million U.S. adults, 300,329 from the UK Biobank (UKBB) and 57,644 from the Biobank Japan (BBJ). We assessed liver stiffness measurement (LSM) ≥8 kPa and liver-related events occurring within 3 and 10 years (3/10 year-LREs) as outcomes. We defined MASLD, MetALD, and ALD according to recent international recommendations. RESULTS: FIB4 sensitivity for LSM ≥ 8 kPa was low (27.7%), but it ranged approximately 80%-90% for 3-year LREs. Using FIB4, 22%-57% of subjects across the three cohorts were identified as candidates for vibration-controlled transient elastography (VCTE), which was mostly avoidable (positive predictive value of FIB4 ≥ 1.3 for LSM ≥ 8 kPa ranging 9.5%-13% across different SLD categories). Sensitivity for LSM ≥ 8 kPa and LREs increased with increasing alcohol intake (ALD>MetALD>MASLD) and age classes. For individuals aged ≥65 years, using the recommended age-adjusted FIB4 cut-off (≥2) substantially reduced sensitivity for LSM ≥ 8 kPa and LREs. CONCLUSIONS: The first-step FIB4 EASL CP is poorly accurate and feasible for individuals at risk of SLD in the general population. It is crucial to enhance the screening strategy with a first-step approach able to reduce unnecessary VCTEs and optimise their yield.
引用
- De Vincentis A, Tavaglione F, Namba S, et al. Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population. Aliment Pharmacol Ther. 2024. PMID: 38497224. doi:10.1111/apt.17953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。